The development and implementation of drugs to correct erectile dysfunction, into clinical practice is a promising direction in medicine and pharmacy. Levitra (vardenafil) is a modern and powerful selective inhibitor of phosphodiesterase- 5 (PDE-5), and an effective and safe therapy for erectile dysfunction. Currently, Levitra (vardenafil) is being evaluated and approved in many countries around the world. For 8 months in 2003 Levitra (vardenafil) officially entered the market in the 39 countries that made up almost 90% of the market sales of PDE-5 inhibitors worldwide. All EU markets Levitra (vardenafil) was issued in 4 - 12 weeks after it was approved. At the U.S. market Levitra (vardenafil)was released in late August, 2003, in 13 months after receiving an accepting letter of FDA. Introduction of innovative new drugs such as vardenafil into the clinical practice to treat erectile dysfunction significantly accelerated the growth of this group of medicines at the market. The possibility of an effective and safe treatment for erectile dysfunction, along with informational support provided the increasing number of men who applied to doctors for medical assistance. Now, approximately 60-90% of physicians involved in the treatment of erectile dysfunction, tried Levitra (vardenafil), by appointing it from 55 to 95% of patients. The product quickly received the endorsement of European professionals. Buy Levitra here...